XML 143 R20.htm IDEA: XBRL DOCUMENT v2.4.0.8
Share-Based Compensation
6 Months Ended
Jun. 30, 2013
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Share-Based Compensation
 Share-Based Compensation
A broad-based stock incentive plan, the 2006 Stock Incentive Plan, was adopted by the Corporation’s shareholders on April 18, 2006 and was amended and restated on May 2, 2012. Awards granted under this Plan as of June 30, 2013 were stock options granted in 2007, 2008, 2009, 2012 and 2013 and long-term restricted shares issued in 2010, 2011, and 2012. In addition, the Corporation has nonqualified stock option agreements outside of the 2006 Stock Incentive Plan. Grants under the nonqualified stock option agreements were made from 2005 to 2007.
Stock Options
The expense recorded for stock options was $26, and $1 for the first six months ended June 30, 2013 and 2012, respectively. The maximum option term is ten years and the options generally vest over three years as follows: one-third after one year from the grant date, two-thirds after two years and completely after three years.

The fair value of options granted in the second quarter of 2013 was determined using the following weighted-average assumptions as of grant date:
Risk free interest rate
 
1.20
%
Dividend yield
 
3.08
%
Volatility
 
32.62
%

 
Outstanding
 
Exercisable
 
Number
 
Weighted Average
Remaining
Contractual Life
(Years)
 
Number
 
Weighted Average
Exercise Price
Range of Exercise Prices
 
 
 
 
 
 
 
$5.34-$5.39
37,500

 
8.41
 
2,500

 
$
5.34

$9.07
107,863

 
9.86
 

 

$14.47
82,000

 
4.60
 
82,000

 
14.47

$15.35-$16.50
52,500

 
3.71
 
52,500

 
15.78

$19.10
30,000

 
2.59
 
30,000

 
19.10

$19.17
30,000

 
1.59
 
30,000

 
19.17

Outstanding at end of period
339,863

 
6.11
 
197,000

 
16.12



A summary of the status of stock options at June 30, 2013 and 2012 and changes during the year then ended is presented in the table below:
 
 
2013
 
2012
 
Options
 
Weighted Average
Exercise
Price per Share
 
Options
 
Weighted Average
Exercise
Price per Share
Outstanding at beginning of period
232,000

 
14.50

 
197,000

 
16.12

Granted
107,863

 
9.07

 
35,000

 
$5.39
Forfeited or expired

 

 

 

Exercised

 

 

 

Stock dividend or split

 

 

 

Outstanding at end of period
339,863

 
12.78

 
232,000

 
14.50

Exercisable at end of period
197,000

 
16.12

 
197,000

 
16.12



There were no options exercised during the first six months of 2013 therefore the total intrinsic value of options exercised was $0. The total intrinsic value of all options outstanding at June 30, 2013 was $120.

Restricted Shares

In 2012, the Corporation issued 62,105 shares of long-term restricted stock. The market price of the Corporation’s common shares on the date of grant of the long-term restricted stock was $5.39 per share. Shares of long-term restricted stock generally vest in two equal installments on the second and third anniversaries of the date of grant, or upon the earlier death or disability of the recipient or a qualified change of control of the Corporation. The expense recorded for long-term restricted stock for the six months ended June 30, 2013 and 2012 was $125, and $144 respectively.

The market price of the Corporation’s common shares at the date of grant is used to estimate the fair value of restricted stock awards. A summary of the status of restricted shares at June 30, 2013 is presented in the table below:
 
 
Nonvested
Shares
 
Weighted Average
Grant Date
Fair Value
Nonvested at January 1, 2013
143,031

 
$
5.07

Granted

 

Vested
(52,499
)
 
4.68

Forfeited or expired

 

Nonvested at June 30, 2013
90,532

 
8.00


Stock Appreciation Rights (“SARS”)
In 2006, the Corporation issued an aggregate of 30,000 SARS at $19.00 per share, 15,500 of which have expired due to employee terminations. The SARS vest over three years as follows: one-third after one year from the grant date, two-thirds after two years and completely after three years. Any unexercised portion of the SARS shall expire at the end of the stated term which is specified at the date of grant and shall not exceed ten years. The SARS issued in 2006 will expire in January 2016. The expense recorded for SARS for the six months ended June 30, 2013, was $5 and for 2012 was $2.